Evidence map›Paper›PMID 32917903›Full record

ArticleNature communications2020

Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility.

Sigrid Gouma, Kangchon Kim, Madison E Weirick, Megan E Gumina, Angela Branche, David J Topham, Emily T Martin, Arnold S Monto, Sarah Cobey, Scott E Hensley

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A guide to adaptive immune memory.Nature reviews. Immunology · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A speed limit on serial strain replacement from original antigenic sin.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Sigrid GoumaDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0002-7853-8340
Kangchon KimDepartment of Ecology & Evolution, University of Chicago, Chicago, IL, 60637, USA.
Madison E WeirickDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Megan E GuminaDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Angela BrancheDivision of Infectious Diseases, University of Rochester Medical Center, Rochester, NY, 14642, USA.
David J TophamDepartment of Medicine and Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, Rochester, NY, 14642, USA.ORCID http://orcid.org/0000-0002-9435-8673
Emily T MartinDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Arnold S MontoDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Sarah CobeyDepartment of Ecology & Evolution, University of Chicago, Chicago, IL, 60637, USA.
Scott E HensleyDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. hensley@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-2928-7506
University of Pennsylvania · USUniversity of Chicago · USUniversity of Michigan · USUniversity of Rochester Medical Center · US

Funding

Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness ResearchU01IP000474 · IP · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S · 2011 to 2015
$6.2M
Impact of prior influenza exposures on antibody repertoires to new viral strainsR01AI108686 · NIAID · WISTAR INSTITUTE · PI HENSLEY, SCOTT ERIC · 2014 to 2022
$3.7M
The effect of human pre-exposure history on antigenic drift of influenza virusesR01AI113047 · NIAID · WISTAR INSTITUTE · PI HENSLEY, SCOTT ERIC · 2014 to 2018
$2.5M
Household Studies of Influenza and Other Respiratory Viruses - Supplement: EV D68 SurveillanceR01AI097150 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S, OHMIT, SUZANNE · 2012 to 2015
$2.0M
NCIRD CDC HHS U01 IP000474NCIRD CDC HHS U01 IP001034NIAID NIH HHS HHSN272201400005CNIAID NIH HHS R01 AI097150NIAID NIH HHS R01 AI108686NIAID NIH HHS R01 AI113047
6 · The paper itself

Abstract

Influenza virus exposures in childhood can establish long-lived memory B cell responses that can be recalled later in life. Here, we complete a large serological survey to elucidate the specificity of antibodies against contemporary H3N2 viruses in differently aged individuals who were likely primed with different H3N2 strains in childhood. We find that most humans who were first infected in childhood with H3N2 viral strains from the 1960s and 1970s possess non-neutralizing antibodies against contemporary 3c2.A H3N2 viruses. We find that 3c2.A H3N2 virus infections boost non-neutralizing H3N2 antibodies in middle-aged individuals, potentially leaving many of them in a perpetual state of 3c2.A H3N2 viral susceptibility.

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, NeutralizingAntibodies, ViralAntigens, ViralChildChild, PreschoolDisease SusceptibilityFemaleHemagglutinin Glycoproteins, Influenza VirusHumansInfantInfluenza A Virus, H3N2 SubtypeInfluenza, HumanAntibodies, NeutralizingAntibodies, ViralAntigens, ViralHemagglutinin Glycoproteins, Influenza VirusRecombinant Proteins

Identifiers

PMID32917903
PMCPMC7486384
OpenAlexW3085492354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.